Profiel
Ji-Hoon Sohn is currently Chief Executive Officer & Director at PharmaResearch Co., Ltd. since 2025.
Formerly, Mr. Sohn was President, Co-Chief Executive Officer & Director at DONG WHA PHARM Co., Ltd. Mr. Sohn was Chief Executive Officer & Executive Director at Hugel, Inc. from 2018 to 2024.
Education includes an MBA from Boston University conferred in 1988 and an undergraduate degree from Korea University.
Actieve functies van Ji-Hoon Sohn
| Bedrijven | Functie | Begin |
|---|---|---|
| PHARMARESEARCH CO., LTD. | Algemeen Directeur | 25-03-2025 |
Eerdere bekende functies van Ji-Hoon Sohn
| Bedrijven | Functie | Einde |
|---|---|---|
| HUGEL, INC. | Algemeen Directeur | - |
| DONGWHA PHARM.CO.,LTD | Algemeen Directeur | - |
Opleiding van Ji-Hoon Sohn
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
DONG WHA PHARM Co., Ltd.
DONG WHA PHARM Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical and medicinal chemicals | Health Technology |
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Korea University
Korea University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hugel, Inc.
Hugel, Inc. BiotechnologyHealth Technology Manufactures and supplies toxin products, cosmetics, medical devices and pharmaceuticals | Health Technology |
PharmaResearch Co., Ltd.
PharmaResearch Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development of refined raw materials for cell and tissue regeneration through marine bio technology | Health Technology |
















